Free Trial

Fuller & Thaler Asset Management Inc. Purchases 161,454 Shares of Azenta, Inc. $AZTA

Azenta logo with Medical background

Key Points

  • Fuller & Thaler Asset Management Inc. increased its stake in Azenta, Inc. by 27.5%, now holding 1.64% of the company worth approximately $25.9 million.
  • Azenta reported a quarterly earnings per share of $0.19, exceeding analysts' expectations of $0.13, yet its revenue fell short at $143.94 million compared to the expected $149.64 million.
  • Despite recent analyst upgrades and an average price target of $35.75, Azenta's stock is currently down 0.4% at $30.29, with a twelve-month price range between $23.91 and $55.63.
  • MarketBeat previews top five stocks to own in October.

Fuller & Thaler Asset Management Inc. increased its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 27.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 747,801 shares of the company's stock after purchasing an additional 161,454 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 1.64% of Azenta worth $25,904,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Farther Finance Advisors LLC raised its stake in Azenta by 788.1% during the 1st quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock valued at $33,000 after acquiring an additional 859 shares during the last quarter. Quarry LP acquired a new stake in shares of Azenta during the fourth quarter worth $110,000. Caitong International Asset Management Co. Ltd raised its position in shares of Azenta by 13,184.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,524 shares of the company's stock worth $87,000 after buying an additional 2,505 shares during the period. Sterling Capital Management LLC raised its position in shares of Azenta by 39.8% in the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock worth $143,000 after buying an additional 813 shares during the period. Finally, Deutsche Bank AG raised its position in Azenta by 28.5% in the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock valued at $210,000 after purchasing an additional 931 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Stock Down 2.1%

AZTA traded down $0.65 during trading on Monday, hitting $30.90. The company had a trading volume of 102,865 shares, compared to its average volume of 763,242. The firm's 50-day moving average price is $31.32 and its 200 day moving average price is $32.56. Azenta, Inc. has a one year low of $23.91 and a one year high of $55.63. The company has a market capitalization of $1.42 billion, a PE ratio of -12.77 and a beta of 1.59.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.13 by $0.06. The company had revenue of $143.94 million during the quarter, compared to the consensus estimate of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The company's quarterly revenue was up .0% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 EPS. Sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Evercore ISI set a $33.00 price target on Azenta and gave the stock an "in-line" rating in a research note on Tuesday, August 5th. Needham & Company LLC cut their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th. Stephens initiated coverage on shares of Azenta in a research note on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price target on the stock. Finally, Raymond James Financial raised shares of Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 target price on the stock in a research report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $35.75.

View Our Latest Stock Report on Azenta

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Stories

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.